Chantix

Chantix anti-smoking pill raises risk of heart attacks, says FDA

Monday, July 11, 2011 by: Sally Oaken
Tags: Chantix, heart attacks, health news

eTrust Pro Certified

Most Viewed Articles
Popular on Facebook
Malaysia Airlines Flight 370 now clearly a government cover-up: All evidence contradicts official story
White House admits staging fake vaccination operation to gather DNA from the public
10 other companies that use the same Subway yoga mat chemical in their buns
High-dose vitamin C injections shown to annihilate cancer
Irrefutable proof we are all being sprayed with poison: 571 tons of toxic lead 'chemtrailed' into America's skies every year
EXCLUSIVE: Natural News tests flu vaccine for heavy metals, finds 25,000 times higher mercury level than EPA limit for water
Truvia sweetener a powerful pesticide; scientists shocked as fruit flies die in less than a week from eating GMO-derived erythritol
Senator who attacked Doctor Oz over dietary supplements received over $146,000 in campaign contributions from Big Pharma mega-retailer and Monsanto
Global warming data FAKED by government to fit climate change fictions
U.S. treating meat with ammonia, bleach and antibiotics to kill the '24-hour sickness'
HOAX confirmed: Michelle Obama 'GMOs for children' campaign a parody of modern agricultural politics
Ben and Jerry's switches to non-GMO, Fair Trade ice cream ingredients
Battle for humanity nearly lost: global food supply deliberately engineered to end life, not nourish it
Diet soda, aspartame linked to premature deaths in women
Cannabis kicks Lyme disease to the curb
Elliot Rodger, like nearly all young killers, was taking psychiatric drugs (Xanax)
Harvard research links fluoridated water to ADHD, mental disorders
Right to farm being stripped from Americans: Michigan to criminalize small family farms with chickens, goats, honey bees and more
Delicious
(NaturalNews) Early in June, the FDA released a report officially linking the smoking cessation drug Chantix to an increased risk of cardiovascular health problems including heart attacks.

The increased heart attack risk is low and is noted primarily among those who are already experiencing problems with their cardiovascular health, but the connection has been proven conclusively, and has led to FDA to require a new series of randomized, placebo-controlled trials which may eventually result in the removal of the drug from the market.

For the study in question, 700 smokers with cardiovascular disease participated in an independent randomized trial in which some of the subjects were treated with Chantix and some were treated with a placebo.

Chantix was proven to be effective in helping patients quit smoking for up to one year. But unfortunately, the subjects who received the drug experienced a higher incidence of adverse cardiovascular events that those who were provided with the placebo.

Chantix has previously been associated with a wide variety of other negative side effects, which have resulted in a ruling requiring Pfizer, the company that produces Chantix, to label the drug with restrictive "black box" warnings.

Many of these side effects are psychological and include agitation, depression, nightmares and suicidal thoughts. These symptoms have occurred in patients with no history of depression or mental illness, and those with an existing history of mental illness have experienced a worsening of their symptoms as they begin taking Chantix. These side effects have led to slow sales for what was originally believed to be a promising smoking cessation aid.

The Food and Drug Administration has been hesitant to place additional restrictions on Pfizer's production of Chantix due to the possibility that its benefits as a smoking cessation aid may outweigh the harm caused by its possible side effects.

As new evidence comes to light about the dangers of smoking, the FDA must balance the potential risk of the drug against the greater good it provides by lowering the rates of cancer and heart disease associated with smoking. But ironically, many of patients who begin taking Chantix are smokers who have developed heart problems and are interesting in smoking cessation to protect themselves from the risk of heart attacks.

Meanwhile, as they have been for generations, tobacco companies are engaged in vigorous efforts to reduce the stringency of labeling requirements on cigarette packaging and decrease restrictions on cigarette production and marketing.

Join over four million monthly readers. Your privacy is protected. Unsubscribe at any time.
comments powered by Disqus
Take Action: Support NaturalNews.com by linking back to this article from your website

Permalink to this article:

Embed article link: (copy HTML code below):

Reprinting this article:
Non-commercial use OK, cite NaturalNews.com with clickable link.

Follow Natural News on Facebook, Twitter, Google Plus, and Pinterest

Advertise with NaturalNews...

Support NaturalNews Sponsors:

Advertise with NaturalNews...

GET SHOW DETAILS
+ a FREE GIFT

Sign up for the FREE Natural News Email Newsletter

Receive breaking news on GMOs, vaccines, fluoride, radiation protection, natural cures, food safety alerts and interviews with the world's top experts on natural health and more.

Join over 7 million monthly readers of NaturalNews.com, the internet's No. 1 natural health news site. (Source: Alexa.com)

Your email address *

Please enter the code you see above*

No Thanks

Already have it and love it!

Natural News supports and helps fund these organizations:

* Required. Once you click submit, we will send you an email asking you to confirm your free registration. Your privacy is assured and your information is kept confidential. You may unsubscribe at anytime.